New trends in the endocrine treatment of breast cancer.
Maass
H
H
Universitäts-Frauenklinik, Hamburg, FRG.
Jonat
W
W
Eidtmann
H
H
Kunz
T
T
Kügler
G
G
D000735:Androstenedione / Q000031:analogs & derivatives / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000737:chemistry / Q000188:drug therapy*; D002064:Buserelin / Q000031:analogs & derivatives / Q000627:therapeutic use; D005260:Female; D017273:Goserelin; D006801:Humans; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D013629:Tamoxifen / Q000627:therapeutic use
D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D013629:Tamoxifen; D017273:Goserelin; D000735:Androstenedione; C014594:formestane; D002064:Buserelin